116 related articles for article (PubMed ID: 11154993)
41. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
42. The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.
Hock BD; Haring LF; Steinkasserer A; Taylor KG; Patton WN; McKenzie JL
Leuk Res; 2004 Mar; 28(3):237-41. PubMed ID: 14687618
[TBL] [Abstract][Full Text] [Related]
43. Serum transferrin receptor measurements in hematologic malignancies.
Klemow D; Einsphar D; Brown TA; Flowers CH; Skikne BS
Am J Hematol; 1990 Jul; 34(3):193-8. PubMed ID: 2163585
[TBL] [Abstract][Full Text] [Related]
44. [KL-6 antigen].
Kitamura S
Nihon Rinsho; 1999 Dec; 57 Suppl():772-5. PubMed ID: 10778237
[No Abstract] [Full Text] [Related]
45. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
46. [Quantitative measurement and clinical analysis of serum levels of immunosuppressive acidic protein (IAP) in hematopoietic malignancies].
Hamaguchi H; Karitani Y; Minami N; Tanaka I; Iwata Y; Shirakawa S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1231-6. PubMed ID: 6732251
[TBL] [Abstract][Full Text] [Related]
47. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
48. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
49. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
[No Abstract] [Full Text] [Related]
50. [Haptoglobin level in multiple myeloma, lymphatic leukemia and other proliferative disorders of the lymphoreticular system].
Cieśluk S; Snigurowicz J
Pol Tyg Lek; 1970 Jul; 25(28):1048-50. PubMed ID: 5468584
[No Abstract] [Full Text] [Related]
51. [An analysis of acute leukemia cells TfR expression in children].
Huang G; Liao Q; Luo C; Li F; Fu R
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar; 28(1):55-7. PubMed ID: 10684063
[TBL] [Abstract][Full Text] [Related]
52. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
53. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
54. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
[TBL] [Abstract][Full Text] [Related]
55. Recombinant interleukin-2 treatment before and after autologous stem cell transplantation in hematologic malignancies: clinical and immunologic effects.
De Laurenzi A; Iudicone P; Zoli V; De Rosa L; Guglielmetti M; Pescarollo A; Papetti C; Pacilli L; Lapponi P; Petti N
J Hematother; 1995 Apr; 4(2):113-20. PubMed ID: 7633841
[TBL] [Abstract][Full Text] [Related]
56. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
57. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
58. Serum selenium and reticuloendothelial tumors.
Broghamer WL; McConnell KP; Grimaldi M; Blotcky AJ
Cancer; 1978 Apr; 41(4):1462-6. PubMed ID: 639004
[TBL] [Abstract][Full Text] [Related]
59. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
60. Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Hamaguchi Y; Fujimoto M; Takehara K; Sato S
Clin Exp Rheumatol; 2003; 21(4):429-36. PubMed ID: 12942693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
